Faculty profile

Calvin Law

Back to faculty

ProfessorDepartment of SurgeryUniversity of Toronto

Calvin Law

Professor

Department of Surgery

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
11 publications in the last five years, latest in 2026.
Supervisor on 1 trainee award (1 CIHR), most recently in 2009.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,564

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Patient-reported symptom and urgent healthcare use in neuroendocrine tumors.
Endocrine oncology (Bristol, England) · 2026
Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo model.
Endocrine-related cancer · 2026
Contemporary short-term post-operative outcomes after resection of entero-pancreatic NETs: a population-based study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2026

All 57 publications

Latest funding

Delineating the role of cancer cell plasticity during the progression of pancreatic neuroendocrine tumours
CIHR · 2023 · Co-investigator
$1,093,950
Addressing variation in practice in red blood cells transfusion for patients undergoing gastrointestinal cancer surgery.
CIHR · 2019 · Co-investigator
$210,376
An evaluation of patient reported outcomes, patterns of symptoms severity, survival and healthcare costs for neuroendocrine tumours (NETs).
CIHR · 2018 · Co-investigator
$248,626

All 7 grants and awards

57 publications.

Patient-reported symptom and urgent healthcare use in neuroendocrine tumors.

Hallet J, Noel C, Sutradhar R, Duncan K, Law C, Singh S, Myrehaug S, Coburn N, Chan WC, Gombay A, Eskander A

Endocrine oncology (Bristol, England)2026Open Access

DOI: 10.1530/eo-25-0050 PMID: 41574282

Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo model.

Kulathunga N, Chakraborty R, Li Y, Cherin E, Wang ZZ, Mar S, Khazaee T, Misura A, Lens-Pardo A, Ear PH, Schrader J, Garcia-Carbonero R, Chen L, Huang WY, Tsui H, Singh S, Law C, Hallet J, Demore CE, Leong HS, Michael IP

Endocrine-related cancer2026Open Access

DOI: 10.1530/erc-25-0377 PMID: 41744372

Contemporary short-term post-operative outcomes after resection of entero-pancreatic NETs: a population-based study.

Meloche-Dumas L, Singh S, Law C, Chan WC, Ding A, Armah J, Hallet J

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology2026

DOI: 10.1016/j.ejso.2026.111877 PMID: 42134280

Contemporary Short-Term Outcomes of Liver-Directed Therapy for Neuroendocrine Tumor Liver Metastases.

Meloche-Dumas L, Mercier F, Singh S, Law C, Myrehaug S, Chan W, Hallet J

Annals of surgical oncology20252 citations

DOI: 10.1245/s10434-025-18287-5 PMID: 40946123

Impact of treatment strategy after malignant bowel obstruction in stage IV gastrointestinal cancer: population-based cohort study.

Ribeiro T, Bondzi-Simpson A, Bateni S, Chan WC, Coburn N, Law C, Hallet J

BJS open2025

DOI: 10.1093/bjsopen/zraf171 PMID: 41632870

Tranexamic Acid in Patients Undergoing Liver Resection

Karanicolas PJ, Lin Y, McCluskey SA, Tarshis J, Thorpe KE, Wei A, Dixon E, Porter G, Chaudhury P, Nanji S

Journal of the American Medical Association (JAMA)202444 citationsOpen Access

DOI: 10.1001/jama.2024.11783

Tolerability and outcomes of neuroendocrine tumors treated with PRRT and SBRT.

Nunez JE, Ng S, Chen H, Singh S, Hallet J, Law C, Myrehaug S

Endocrine oncology (Bristol, England)20243 citationsOpen Access

DOI: 10.1530/eo-24-0001 PMID: 39108462

Hepatopancreaticobiliary Resection Arginine Immunomodulation (PRIMe) trial: protocol for a randomised phase II trial of the impact of perioperative immunomodulation on immune function following resection for hepatopancreaticobiliary malignancy.

Behman R, Auer RC, Bubis L, Xu G, Coburn NG, Martel G, Hallet J, Balaa F, Law C, Bertens KA, Abou Khalil J, Karanicolas PJ

BMJ open2024Open Access

DOI: 10.1136/bmjopen-2023-072159 PMID: 38580363

Second primary cancers and survival among neuroendocrine tumor patients.

Bateni SB, Coburn NG, Law C, Singh S, Myrehaug S, Assal A, Hallet J

Endocrine-related cancer20233 citations

DOI: 10.1530/erc-22-0337 PMID: 37184947

Upfront Small Bowel Resection for Small Bowel Neuroendocrine Tumors With Synchronous Metastases: A Propensity-score Matched Comparative Population-based Analysis.

Bennett S, Coburn N, Law C, Mahar A, Zhao H, Singh S, Zuk V, Myrehaug S, Gupta V, Levy J, Hallet J

Annals of surgery202235 citations

DOI: 10.1097/sla.0000000000004647 PMID: 33214481

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Calvin Law

Research

Latest papers

Latest funding

Patient-reported symptom and urgent healthcare use in neuroendocrine tumors.

Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo model.

Contemporary short-term post-operative outcomes after resection of entero-pancreatic NETs: a population-based study.

Contemporary Short-Term Outcomes of Liver-Directed Therapy for Neuroendocrine Tumor Liver Metastases.

Impact of treatment strategy after malignant bowel obstruction in stage IV gastrointestinal cancer: population-based cohort study.

Tranexamic Acid in Patients Undergoing Liver Resection

Tolerability and outcomes of neuroendocrine tumors treated with PRRT and SBRT.

Hepatopancreaticobiliary Resection Arginine Immunomodulation (PRIMe) trial: protocol for a randomised phase II trial of the impact of perioperative immunomodulation on immune function following resection for hepatopancreaticobiliary malignancy.

Second primary cancers and survival among neuroendocrine tumor patients.

Upfront Small Bowel Resection for Small Bowel Neuroendocrine Tumors With Synchronous Metastases: A Propensity-score Matched Comparative Population-based Analysis.

Delineating the role of cancer cell plasticity during the progression of pancreatic neuroendocrine tumours

Addressing variation in practice in red blood cells transfusion for patients undergoing gastrointestinal cancer surgery.

An evaluation of patient reported outcomes, patterns of symptoms severity, survival and healthcare costs for neuroendocrine tumours (NETs).

An evaluation of survival, patient-reported outcomes and costs for advanced gastrointestinal cancers

An evaluation of survival, patient reported outcomes and costs for advanced gastrointestinal cancers

A population-based outcome and economic evaluation of interventions for gastric cancer

Hepatic Metastases from Colorectal Cancer in the Elderly: Optimal Treatment Strategies and Current Patterns of Care in Ontario

Frequent collaborators

Natalie Coburn

Julie Hallet

Simron Singh

Alyson Mahar

Sten Myrehaug

Carol Swallow

Lawrence Paszat

Arun Seth

Alice Wei

Carol-Anne Moulton

Sender Herschorn

Robin Mcleod

Pablo Serrano Aybar

Steven Gallinger

Girish Kulkarni

Angela Assal

Helen Cheung

Chris Dey

Chirag Patel

Yulia Lin

Shereen Ezzat

Paul Karanicolas

Frances Wright

Rinku Sutradhar

Caitlin McGregor

Paul McHardy

Mostafa Atri

Robert Nam